Ascendis Pharma A/S (NASDAQ:ASND) Q3 2025 Earnings Call Transcript November 12, 2025
Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-1.17 EPS, expectations were $-0.41.
Operator: Good day, and welcome to the Third Quarter 2025 Pharma Earnings Conference Call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question, please press 11. If your question has been answered and you’d...
